Company: PSTV
Filing Date: 2025-06-17
Form Type: 8-K
Source: 0001193125-25-142093
Chunk: 2

Company: PLUS THERAPEUTICS, INC.
Filing Date: 2025-06-17
Form: 8-K
Item: Item 9.01
Chunk 2
---
Item 9.01      Financial Statements and Exhibits.  

(d) Exhibits.

   4.1      Form of A& R Series B Warrant.                                                
  10.1      Form of Letter Agreement.                                                     
   104      Cover Page Interactive Data File (embedded within the Inline XBRL document).  

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: June 17, 2025

  PLUS THERAPEUTICS, INC.                                             
  By:                          /s/ Marc H. Hedrick, M. D.             
                               Marc H. Hedrick, M. D.                 
                               President and Chief Executive Officer